A detailed history of Health Invest Partners Ab transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Health Invest Partners Ab holds 7,028 shares of REGN stock, worth $5.29 Million. This represents 3.58% of its overall portfolio holdings.

Number of Shares
7,028
Previous 6,893 1.96%
Holding current value
$5.29 Million
Previous $7.24 Million 1.99%
% of portfolio
3.58%
Previous 4.54%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1024.09 - $1201.76 $138,252 - $162,237
135 Added 1.96%
7,028 $7.39 Million
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $1.32 Million - $1.61 Million
1,500 Added 27.81%
6,893 $7.24 Million
Q1 2024

Apr 25, 2024

BUY
$902.69 - $993.35 $1.28 Million - $1.4 Million
1,414 Added 35.54%
5,393 $5.19 Million
Q4 2023

Jan 30, 2024

BUY
$775.18 - $881.7 $3.01 Million - $3.43 Million
3,886 Added 4178.49%
3,979 $3.49 Million
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $65,647 - $71,274
93 New
93 $67,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $80.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Health Invest Partners Ab Portfolio

Follow Health Invest Partners Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

News

Stay updated on Health Invest Partners Ab with notifications on news.